Jessie DPC Member who inspired the Body Program, after taking GLP-1 medication Alex DPC Member after taking GLP-1 medication Introducing Tirzepatide, the game-changing active pharmaceutical ingredient driving the success of Mounjaro and Zepbound*, empowering thousands to achieve and sustain weight loss through diligent diet and exercise
Tirzepatide's dual mechanism may confer additional metabolic benefits, though cardiovascular outcome trials are still ongoing to provide definitive evidence
Using isotope tracing techniques, researchers observed increased FA uptake by GC B cells in vivo and demonstrated that GC B cells cultured in vitro preferentially metabolize FAs over glucose to generate significant amounts of acetyl-CoA
This C-terminal fragment is used in research to investigate mechanisms of lipid metabolism and adipocyte biology, including experimentally reported effects on lipolysis and related pathways, without the full spectrum of growth-promoting activity associated with the intact hGH molecule
Previous medications like Semaglutide (Wegovy/Ozempic) target only GLP-1, while Tirzepatide (Mounjaro/Zepbound) targets GLP-1 and GIP